Navigation Links
Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22

Opening Bell Ceremony Marks Kendle's 10th Anniversary as Public Company

CINCINNATI, Aug. 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Chairman and CEO Candace Kendle, PharmD, will ring the opening bell at the NASDAQ Stock Market on Aug. 22, 2007, the company's 10th anniversary as a publicly-traded company. The Opening Bell ceremony will take place at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) in New York's Times Square and will be broadcast live on and on the seven-story NASDAQ tower, the largest stationary video screen in the world.

(Logo: )

NASDAQ Opening Bell Ceremony - Webcam Instructions

To view the NASDAQ Opening Bell ceremony, go to or Please note:

-- Viewers must have Windows Media Player to view the webcam (Windows

Media Player is downloadable at no charge from

-- It is recommended viewers download the webcam at 9:15 a.m. so there is

time to troubleshoot in the event of technical difficulties

-- Prior to 9:20 a.m., the webcam will show the Tower; at 9:20 a.m. the

router will be switched and viewers will see inside the MarketSite

studio where the ceremony will take place

-- Viewers should not be alarmed that the webcam is fuzzy. Clarity is

dependent on Internet hook up.

NASDAQ Opening Bell Ceremony - Satellite Feed Information

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. For questions, please contact Jolene Libretto at NASDAQ at (646) 441-5220.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at


Copyright©2007 PR Newswire.

Related biology technology :

1. Merge files financial reports by market opening
2. NASDAQ will continue to list Merge
3. NASDAQ grants Merge more time for compliance
4. NASDAQ will continue to list Merge
5. No word on NASDAQ extension for Merge
6. NASDAQ puts Merge on notice again
7. Midwest life science stocks kept sizzling in Q2
8. Madisons PunchStock acquired by Getty Images
9. Midwest life science stocks sizzle in a tepid first quarter
10. Sonic Foundry completes $11.25M stock offer
11. Sonic Foundry sets $3.75 stock price
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking ... Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity as ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):